Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration.

Matsumiya W, Honda S, Yanagisawa S, Miki A, Nagai T, Tsukahara Y.

Pharmacogenomics. 2014 Apr;15(6):833-43. doi: 10.2217/pgs.14.51.

PMID:
24897289
2.

Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.

Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N.

Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3663-72. doi: 10.1167/iovs.12-9619.

PMID:
22570352
3.

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

Brantley MA Jr, Fang AM, King JM, Tewari A, Kymes SM, Shiels A.

Ophthalmology. 2007 Dec;114(12):2168-73.

PMID:
18054635
4.
5.

Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.

Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, Van de Ven JP, Keunen JE, Kirchhof B, Hoyng CB, Klevering BJ, Koenekoop RK, Fauser S, den Hollander AI.

Ophthalmology. 2012 Nov;119(11):2304-11. doi: 10.1016/j.ophtha.2012.05.040. Epub 2012 Jul 26.

PMID:
22840423
6.

Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.

Yamashiro K, Tomita K, Tsujikawa A, Nakata I, Akagi-Kurashige Y, Miyake M, Ooto S, Tamura H, Yoshimura N.

Am J Ophthalmol. 2012 Jul;154(1):125-36. doi: 10.1016/j.ajo.2012.01.010. Epub 2012 Apr 1.

PMID:
22465368
7.
8.

[Age-related Macular Degeneration in the Japanese].

Yoshimura N.

Nippon Ganka Gakkai Zasshi. 2016 Mar;120(3):163-88; discussion 189. Japanese.

PMID:
27164756
9.

CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.

Hayashi H, Yamashiro K, Gotoh N, Nakanishi H, Nakata I, Tsujikawa A, Otani A, Saito M, Iida T, Matsuo K, Tajima K, Yamada R, Yoshimura N.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5914-9. doi: 10.1167/iovs.10-5554. Epub 2010 Jun 23.

PMID:
20574013
10.

[Retinal and choroidal thickness changes following intravitreal ranibizumab injection for exudative age-related macular degeneration].

Ogasawara M, Maruko I, Sugano Y, Ojima A, Sekiryu T, Iida T.

Nippon Ganka Gakkai Zasshi. 2012 Jul;116(7):643-9. Japanese.

PMID:
22844783
11.

Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.

Inoue M, Arakawa A, Yamane S, Kadonosono K.

Retina. 2013 May;33(5):990-7. doi: 10.1097/IAE.0b013e3182755793.

PMID:
23446653
12.

Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.

Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA Jr.

Br J Ophthalmol. 2009 May;93(5):610-3. doi: 10.1136/bjo.2008.150995. Epub 2008 Dec 17.

13.
14.

Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.

Wegscheider BJ, Weger M, Renner W, Steinbrugger I, März W, Mossböck G, Temmel W, El-Shabrawi Y, Schmut O, Jahrbacher R, Haas A.

Ophthalmology. 2007 Apr;114(4):738-42.

PMID:
17398321
15.
16.

Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD.

Kloeckener-Gruissem B, Barthelmes D, Labs S, Schindler C, Kurz-Levin M, Michels S, Fleischhauer J, Berger W, Sutter F, Menghini M.

Invest Ophthalmol Vis Sci. 2011 Jul 1;52(7):4694-702. doi: 10.1167/iovs.10-6080.

PMID:
21282580
17.

Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.

Nischler C, Oberkofler H, Ortner C, Paikl D, Riha W, Lang N, Patsch W, Egger SF.

Acta Ophthalmol. 2011 Jun;89(4):e344-9. doi: 10.1111/j.1755-3768.2010.02080.x. Epub 2011 Jan 14.

18.

Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population.

Habibi I, Sfar I, Kort F, Aounallah-Skhiri H, Chebil A, Chouchene I, Bouraoui R, Limaiem R, Largheche L, Jendoubi-Ayed S, Makhlouf M, Ben Abdallah T, Ayed K, El Matri L, Gorgi Y.

Ophthalmic Res. 2013;49(4):177-84. doi: 10.1159/000345068. Epub 2013 Jan 10.

PMID:
23306536
19.

Genetic variants in the SKIV2L gene in exudative age-related macular degeneration in the Japanese population.

Yoneyama S, Sakurada Y, Mabuchi F, Sugiyama A, Kubota T, Iijima H.

Ophthalmic Genet. 2014 Sep;35(3):151-5. doi: 10.3109/13816810.2014.921313. Epub 2014 May 27.

PMID:
24865191

Supplemental Content

Support Center